Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer's disease
- PMID: 33256871
- DOI: 10.1017/neu.2020.43
Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer's disease
Abstract
Objective: The present study was designed to test the hypothesis that there is a reduction in the activity of the enzyme cytochrome c oxidase (Cox) in Alzheimer's disease (AD).
Methods: Systematic review of literature and meta-analysis were used with data obtained from the PubMed, Scopus, MEDLINE, Lilacs, Eric and Cochrane. The keywords were Alzheimer's AND Cox AND mitochondria; Alzheimer's AND Cox AND mitochondria; Alzheimer's AND complex IV AND mitochondria. A total of 1372 articles were found, 23 of them fitting the inclusion criteria. The data were assembled in an Excel spreadsheet and analysed using the RevMan software. A random effects model was adopted to the estimative of the effect.
Results: The data shows a significant decrease in the activity of the Cox AD patients and animal models.
Conclusion: Cox enzyme may be an important molecular component involved in the mechanisms underlying AD. Therefore, this enzyme may represent a possible new biomarker for the disease as a complementary diagnosis and a new treatment target for AD.
Keywords: Alzheimer’s disease; electron transport complex IV; meta-analysis; mitochondria.
Similar articles
-
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.Neurology. 1995 Mar;45(3 Pt 1):482-6. doi: 10.1212/wnl.45.3.482. Neurology. 1995. PMID: 7898701
-
Electron transport chain defects in Alzheimer's disease brain.Neurology. 1994 Jun;44(6):1090-6. doi: 10.1212/wnl.44.6.1090. Neurology. 1994. PMID: 8208407
-
[Effects of acupuncture and moxibustion on energy metabolism-related protein of hippocampal neuron mitochondria in Alzheimer's disease rats].Zhongguo Zhen Jiu. 2013 Oct;33(10):913-8. Zhongguo Zhen Jiu. 2013. PMID: 24377225 Chinese.
-
Mitochondria in Alzheimer's disease.Int Rev Neurobiol. 2002;53:341-85. doi: 10.1016/s0074-7742(02)53013-0. Int Rev Neurobiol. 2002. PMID: 12512346 Review. No abstract available.
-
Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification.J Alzheimers Dis. 2006 Jul;9(2):155-66. doi: 10.3233/jad-2006-9208. J Alzheimers Dis. 2006. PMID: 16873963 Review.
Cited by
-
Oxidative stress-mediated neuroinflammation in Alzheimer's disease.Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8189-8209. doi: 10.1007/s00210-024-03188-3. Epub 2024 Jun 4. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38832985 Review.
-
Oxidative Stress Biomarkers and Mitochondrial DNA Copy Number Associated with APOE4 Allele and Cholinesterase Inhibitor Therapy in Patients with Alzheimer's Disease.Antioxidants (Basel). 2021 Dec 10;10(12):1971. doi: 10.3390/antiox10121971. Antioxidants (Basel). 2021. PMID: 34943074 Free PMC article.
-
Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models.J Neural Transm (Vienna). 2025 Feb 11. doi: 10.1007/s00702-025-02891-6. Online ahead of print. J Neural Transm (Vienna). 2025. PMID: 39932549 Review.
-
Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer's Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration.Brain Sci. 2023 Mar 18;13(3):511. doi: 10.3390/brainsci13030511. Brain Sci. 2023. PMID: 36979320 Free PMC article.
-
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.Acta Pharm Sin B. 2022 Feb;12(2):511-531. doi: 10.1016/j.apsb.2021.06.014. Epub 2021 Jun 30. Acta Pharm Sin B. 2022. PMID: 35256932 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical